These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9853515)

  • 1. Canarypox virus-mediated interleukin 12 gene transfer into murine mammary adenocarcinoma induces tumor suppression and long-term antitumoral immunity.
    Puisieux I; Odin L; Poujol D; Moingeon P; Tartaglia J; Cox W; Favrot M
    Hum Gene Ther; 1998 Nov; 9(17):2481-92. PubMed ID: 9853515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Canarypox virus expressing wild type p53 for gene therapy in murine tumors mutated in p53.
    Odin L; Favrot M; Poujol D; Michot JP; Moingeon P; Tartaglia J; Puisieux I
    Cancer Gene Ther; 2001 Feb; 8(2):87-98. PubMed ID: 11263530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-12 gene therapy of a weakly immunogenic mouse mammary carcinoma results in reduction of spontaneous lung metastases via a T-cell-independent mechanism.
    Rakhmilevich AL; Janssen K; Hao Z; Sondel PM; Yang NS
    Cancer Gene Ther; 2000 Jun; 7(6):826-38. PubMed ID: 10880012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of canarypox virus (ALVAC)-mediated cytokine expression on murine prostate tumor growth.
    Kawakita M; Rao GS; Ritchey JK; Ornstein DK; Hudson MA; Tartaglia J; Paoletti E; Humphrey PA; Harmon TJ; Ratliff TL
    J Natl Cancer Inst; 1997 Mar; 89(6):428-36. PubMed ID: 9091644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of murine prostate tumor growth and activation of immunoregulatory cells with recombinant canarypox viruses.
    Griffith TS; Kawakita M; Tian J; Ritchey J; Tartaglia J; Sehgal I; Thompson TC; Zhao W; Ratliff TL
    J Natl Cancer Inst; 2001 Jul; 93(13):998-1007. PubMed ID: 11438565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity of whole-cell tumor preparations infected with the ALVAC viral vector.
    Ghose A; Iakhnina E; Spaner D; Tartaglia J; Berinstein NL
    Hum Gene Ther; 2000 Jun; 11(9):1289-301. PubMed ID: 10890739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune responsiveness to a murine mammary carcinoma modified to express B7-1, interleukin-12, or GM-CSF.
    Aruga E; Aruga A; Arca MJ; Lee WM; Yang NS; Smith JW; Chang AE
    Cancer Gene Ther; 1997; 4(3):157-66. PubMed ID: 9171934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viral vector delivery in solid-state vehicles: gene expression in a murine prostate cancer model.
    Siemens DR; Austin JC; Hedican SP; Tartaglia J; Ratliff TL
    J Natl Cancer Inst; 2000 Mar; 92(5):403-12. PubMed ID: 10699070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor efficacy of adenocarcinoma cells engineered to produce interleukin 12 (IL-12) or other cytokines compared with exogenous IL-12.
    Cavallo F; Signorelli P; Giovarelli M; Musiani P; Modesti A; Brunda MJ; Colombo MP; Forni G
    J Natl Cancer Inst; 1997 Jul; 89(14):1049-58. PubMed ID: 9230887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I study of the intratumoral administration of recombinant canarypox viruses expressing B7.1 and interleukin 12 in patients with metastatic melanoma.
    Triozzi PL; Allen KO; Carlisle RR; Craig M; LoBuglio AF; Conry RM
    Clin Cancer Res; 2005 Jun; 11(11):4168-75. PubMed ID: 15930353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intratumoral administration of a recombinant canarypox virus expressing interleukin 12 in patients with metastatic melanoma.
    Triozzi PL; Strong TV; Bucy RP; Allen KO; Carlisle RR; Moore SE; Lobuglio AF; Conry RM
    Hum Gene Ther; 2005 Jan; 16(1):91-100. PubMed ID: 15703492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of neutrophils and lymphocytes in inhibition of a mouse mammary adenocarcinoma engineered to release IL-2, IL-4, IL-7, IL-10, IFN-alpha, IFN-gamma, and TNF-alpha.
    Musiani P; Allione A; Modica A; Lollini PL; Giovarelli M; Cavallo F; Belardelli F; Forni G; Modesti A
    Lab Invest; 1996 Jan; 74(1):146-57. PubMed ID: 8569177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined CXC chemokine and interleukin-12 gene transfer enhances antitumor immunity.
    Palmer K; Hitt M; Emtage PC; Gyorffy S; Gauldie J
    Gene Ther; 2001 Feb; 8(4):282-90. PubMed ID: 11313802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IFN-gamma-independent synergistic effects of IL-12 and IL-15 induce anti-tumor immune responses in syngeneic mice.
    Comes A; Di Carlo E; Musiani P; Rosso O; Meazza R; Chiodoni C; Colombo MP; Ferrini S
    Eur J Immunol; 2002 Jul; 32(7):1914-23. PubMed ID: 12115611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratumoral coinjection of two adenoviruses, one encoding the chemokine IFN-gamma-inducible protein-10 and another encoding IL-12, results in marked antitumoral synergy.
    Narvaiza I; Mazzolini G; Barajas M; Duarte M; Zaratiegui M; Qian C; Melero I; Prieto J
    J Immunol; 2000 Mar; 164(6):3112-22. PubMed ID: 10706701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In situ expression of soluble B7-1 in the context of oncolytic herpes simplex virus induces potent antitumor immunity.
    Todo T; Martuza RL; Dallman MJ; Rabkin SD
    Cancer Res; 2001 Jan; 61(1):153-61. PubMed ID: 11196154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical phase I intratumoral administration of two recombinant ALVAC canarypox viruses expressing human granulocyte-macrophage colony-stimulating factor or interleukin-2: the transgene determines the composition of the inflammatory infiltrate.
    Hofbauer GF; Baur T; Bonnet MC; Tartour E; Burg G; Berinstein NL; Dummer R
    Melanoma Res; 2008 Apr; 18(2):104-11. PubMed ID: 18337646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4 T cells inhibit in vivo the CD8-mediated immune response against murine colon carcinoma cells transduced with interleukin-12 genes.
    Martinotti A; Stoppacciaro A; Vagliani M; Melani C; Spreafico F; Wysocka M; Parmiani G; Trinchieri G; Colombo MP
    Eur J Immunol; 1995 Jan; 25(1):137-46. PubMed ID: 7843224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different tumours, transduced with different cytokine genes as G-CSF and IL-2, show inhibition of tumour take through neutrophil activation but differ in T cell functions.
    Stoppacciaro A; Forni G; Colombo MP
    Folia Biol (Praha); 1994; 40(1-2):89-99. PubMed ID: 7525363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene transfer of a secretable form of IL-15 in murine adenocarcinoma cells: effects on tumorigenicity, metastatic potential and immune response.
    Meazza R; Lollini PL; Nanni P; De Giovanni C; Gaggero A; Comes A; Cilli M; Di Carlo E; Ferrini S; Musiani P
    Int J Cancer; 2000 Aug; 87(4):574-81. PubMed ID: 10918200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.